SLA 1.12% $4.50 silk laser australia limited

hiv,hcv and liver disease

  1. 90 Posts.
    Undated but from 2007 I think
    http://www.eatg.org/Press-Publications/Press-Releases/European-researchers-regulators-the-pharmaceutical-industry-and-activists-demand-better-treatment-for-people-with-hepatitis-C-and-HIV


    "Studies should not just be conducted of drugs to cure or treat HCV infection but also to slow or reverse liver fibrosis."

    Sounds like Ropren.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.